Table 2.

Multivariable Analysis of Cancer-Specific Survival in Stage II and III Melanoma Patients

Variable	HR (CIs)	p
Age 45–59 vs. <45 years	1.16 (0.94 − 1.43)	0.1582
Age ≥60 vs. <45 years	1.66 (1.38 − 1.99)	<0.0001
Female sex	0.76 (0.67 − 0.86)	<0.0001
Mitotic rate >1 vs. 0 or ≤1	1.58 (1.25 − 1.98)	<0.0001

CI, confidence interval; HR, hazard ratio.